Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Action-HD: Bupropion for Apathy in Huntington's Disease
NCT01914965Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jun 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in apathy comparing Bupropion Sequence with Placebo Sequence (2 arms). Primary endpoint: Apathy Evaluation Scale - Informant at 10 weeks. Started Jun 2012; status: completed.
02
Drugs
bupropion
03
Conditions
apathy
Beyond the preview
Go deeper on NCT01914965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01914965.